Friday, January 20, 2017 3:55:19 PM
To cut to the chase I think what they are doing is
1.Cleaning up their balance sheet(I.E. getting rid of their bills)
2.Increasing their stockholder Equity (Nasdaq rule I believe on Nasdaq Capital Market its 2.5 Million) Letter being written or already sent to get extension to regain compliance with the minimum equity rule)
3.Increasing exposure I.E. multiple Insurance companies and now moving International with "BEST MED OPINION"
http://www.bestmedopinions.com/
4.INCREASING LIQUIDITY and Increasing the number of INSTITUTIONAL shareholders
..........
Basically they appear to be doing their Fiduciary duties FOR shareholders in a manner that we despise (dilution),but for good reason if you are an investor and not a flipper.
If you look at the big picture ... the fact that they are expecting to be cash flow positive later this year ... increasing revenue, management seems to be responsible ,taking care of business as they should to get this train really rolling up hill.
They also have more diagnostic tests that haven't hit the market yet.
At some point they will stop dilution I believe ,and I'm counting on it ...
That being said ... I expect the worst and hope for the best always !!
I didn't sell any this morning because I still believe this is worth 3-5 or now 30 - 50.00 a share after R/Split 10:1 and eventually much more than that.I have flipped several times but not selling or flipping any at the very least until its over a buck or rather 10.00 a share.
I think although dilution sucks and is a factor here you should maybe look at the bigger picture;This is not some pos penny stock r/splitting turd.
Today was just more engine revving ... those are just my thoughts on the company and as always ... hope I'm right.
"Diversification is a protection against ignorance. It makes very little sense for those who know what they're doing."
Recent IDXG News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:01:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 11:33:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:05:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:05:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:14:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:16:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:05:18 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/22/2023 08:53:38 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/22/2023 08:20:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 07:47:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 05:27:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2023 09:24:47 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM